In the ongoing battle against COVID-19, the United States has leaned heavily on vaccines as its primary weapon. While vaccination has been a cornerstone of the country’s public health strategy, it's ...

Monoclonal antibodies (mAbs) are manufactured proteins that behave similarly to antibodies found naturally in the body. Researchers initially developed them for treating certain cancers but have now ...

Researchers are increasingly developing antibody therapies to treat infectious diseases. Therapies are being designed to ...

Important adverse events included infusion-related and hypersensitivity reactions in 25 of 306 immunocompromised participants (8.2%) who received pemivibart and anaphylaxis in 4 of 623 participants (0 ...

Monoclonal antibodies -- treatments developed by cloning a cell that makes an antibody -- could help provide an answer to the growing problem of antimicrobial resistance, say scientists. Monoclonal ...

On 7 August 1975, Nature published a paper that has had some of the greatest impacts on science and health care in modern times. The study, by biochemists Georges Köhler and César Milstein, described ...

Artificial intelligence (AI) and "protein language" models can speed the design of monoclonal antibodies that prevent or reduce the severity of potentially life-threatening viral infections, according ...

For the first time this fall, families will be offered season-long protection for infants and some children against respiratory syncytial virus (RSV). The US Food and Drug Administration (FDA) in July ...